| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $4.8M | -52.4% |
| SG&A Expense | $3.5M | -40.7% |
| Operating Income | -$8.8M | +44.5% |
| Interest Expense | $3K | +795.5% |
| Pre-tax Income | -$8.8M | +44.5% |
| Income Tax | $0 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $2K | -99.8% |
| Total Assets | $58K | -91.5% |
| Current Liabilities | $289K | +43.5% |
| Total Liabilities | $315K | +56.9% |
| Stockholders' Equity | -$257K | -152.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15K | +89.5% |
| Financing Cash Flow | $10K | -82.8% |
| — |
| Net Income | -$8.8M | +44.5% |
| EPS (Diluted) | -$0.15 | +42.3% |